A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2])

Am J Cardiol. 2002 Feb 1;89(3):326-30. doi: 10.1016/s0002-9149(01)02235-4.

Authors

Richard E Kuntz¹, Donald S Baim, David J Cohen, Jeffrey J Popma, Joseph P Carrozza, Samin Sharma, Daniel J McCormick, Dwayne A Schmidt, Alexandra J Lansky, Kalon K L Ho, Kimberly J Dandreo, Cindy M Setum, Stephen R Ramee

Affiliation

¹ Brigham and Women's Hospital, Boston, Massachusetts 02215, USA. [email protected]

PMID: 11809436
DOI: 10.1016/s0002-9149(01)02235-4

No abstract available

Publication types

Clinical Trial
Comparative Study
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Angioplasty, Balloon, Coronary
Coronary Angiography
Coronary Thrombosis / drug therapy*
Coronary Thrombosis / mortality
Coronary Thrombosis / surgery*
Disease-Free Survival
Female
Fibrinolytic Agents / administration & dosage
Fibrinolytic Agents / therapeutic use*
Graft Occlusion, Vascular / drug therapy
Graft Occlusion, Vascular / mortality
Graft Occlusion, Vascular / surgery
Hemorheology
Humans
Infusions, Intra-Arterial
Male
Middle Aged
Thrombectomy* / instrumentation
Thrombectomy* / methods
Treatment Outcome
United States
Urokinase-Type Plasminogen Activator / administration & dosage
Urokinase-Type Plasminogen Activator / therapeutic use*

Substances

Fibrinolytic Agents
Urokinase-Type Plasminogen Activator